Even outside the reporting cycle, it is important not to lose sight of the pillar two measures and their ‘bear traps’. A ...
About 4.5 million workers in the United States quit their jobs in 2022, continuing a trend that began after the 2007 Great ...
India - Patenting Inventions Based On Unexpected Results! Legal News and Analysis - India - Intellectual Property - Conventus ...
Employee turnover costs U.S. businesses more than $1 trillion annually. Offering paid time off cuts quitting rates by 35%, ...
The Patent Term Extension (PTE) provisions of 35 U.S.C. § 156 compensate pharmaceutical patent owners for time they are not ...
Anixa Biosciences, Inc. ("Anixa" or the "Company") , a biotechnology company focused on the treatment and prevention of cancer, today announced that the United States Patent and Trademark Office ...
Remains on Track to Initiate an Expansion Study of NUC-7738 in Combination with Pembrolizumab for Patients with PD-1 Inhibitor-Resistant Melanoma in 2025 ...
EPC continues to benefit from a ruling by the US ITC a couple of months ago, which previously confirmed that Innoscience ...
Federal Circuit Ruling Potentially Upends Orange Book Patent Listing Requirements, Expert Analysis Reveals This ruling marks a pivotal moment in Hatch-Waxman practice, potentially altering how ...
ITC's exclusion order continues to prevent Innoscience from importing infringing products into the U.S. We will pursue all necessary legal avenue ...
As previously announced, Eton Pharmaceuticals will hold a virtual Investor Day and report fourth quarter 2024 financial results on Tuesday, March 18, 2025, beginning at 10:00 a.m. ET (9:00 a.m. CT).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results